butyrate glp-1 to combat obesity and obesity‐associated metabolic disorders: Current status and future implications for therapeutic use - Deuren - 2022 - Obesity Reviews Gut–GLP-1 Axis: Fiber, Microbiome &

GLP-1 (glucagon-like peptide-1) medications, such as semaglutide and liraglutide, have become popular in assisting with weight loss, particularly for those with obesity or overweight conditions

Shea Butter & Macadamia Oil: Nourish, moisturize, and improve skin's lipid barrier

Concurrent Use: What Evidence Supports Clinical practice guidelines recommend sequential monotherapy: start with one agent, titrate to target dose, and assess response over 12-16 weeks

Follow the assessment protocol outlined earlier in this guide to determine if any temperature excursion occurred

doi: 10.3390/ijms241914841

Several experiments have demonstrated that it accelerates the healing process of tissues, including transected rat Achilles tendon [5]